Identifying key areas for medical informatics research

Recent achievements in genomics and the increased importance of genetics in healthcare are changing the clinical landscape for both research and the treatment of disease. Helping shape this landscape, researchers have identified opportunities for synergies between biomedical and medical informatics.

Genomic medicine is now integrating molecular medicine, which aims to explain life and disease in terms of the presence and regulation of molecular entities, and personalised medicine, which applies genotypic knowledge to identify predisposition to disease and develops therapies adapted to the genotype of individual patients.

The IST-funded SYMBIOmatics project seeks to stimulate such developments and help identify synergies between bioinformatics and medical/health informatics. Completing in September 2006, SYMBIOmatics has already documented the current status of research in biomedical informatics in Europe and identified several important areas of opportunity.

By systematically surveying European expert opinion and analysing the results of Internet surveys, the project team have produced a draft SYMBIOmatics White Paper, which was presented at the ‘ICT for Bio-Medical Sciences’ conference in Brussels on 29-30 June 2006. The paper describes thirty-one areas identified as potential opportunities or challenges, based on the results of the project, and input from an earlier study carried out by another IST project, BIOINFOMED.

Using both facilitated workshops and further online consultation, the project team narrowed the total down to 14 areas considered the highest priority for further research. These are:

  • ID area name priority.
  • Medical genetics databases and initiatives.
  • Gene expression information in medical diagnostics and prognostics.
  • Modelling and simulation of biological structures, processes and diseases.
  • Integration of data from biosensors and medical devices with clinical information systems.
  • Integration of patient molecular data into electronic health records.
  • Systems for clinical decision making.
  • Semantic interoperability and ontologies in biomedicine.
  • Technologies for biomedical information integration.
  • Data interoperability and standards.
  • Connecting biobanks to large-scale databases to enable data mining.
  • Patient-risk profiling and lifestyle management.
  • Applied pharmaceutical research.
  • Clinical and ethical issues related to biomedical data processing.

Why are these areas of such high priority? Graham Cameron of the European Bioinformatics Institute (EBI-EMBL) near Cambridge, UK, explains. "In pharmaco-genomics for example, it is well-known that certain drugs will work well on some people, but not on others. We believe that genetic makeup is an important explanation, but genetic testing is needed to confirm that view."

He continues, "Research in these areas could well bring down the cost of genetic testing enough to put it within the reach of the GP practice. So that GPs would be able to test patients for suitability as to certain treatments before commencing treatment with a particular drug. You could work out, with the help of your GP, if your own cholesterol level or diet is dangerous for you personally, according to your genetic makeup. Imagine the difference this could make for personal lifestyle choices!"

Cameron concludes, "SYMBIOmatics is an information gathering and dissemination exercise, but we hope that the research community will digest the results, and that they will influence the future direction of research within the EU."

Contact:
Graham Cameron
European Bioinformatics Institute (EBI-EMBL)
Wellcome Trust Genome Campus
Hinxton (near Cambridge)
United Kingdom
Tel: +44-1223-494467
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: IST Results Portal

Most Popular Now

Digital Health Webinar

14 September 2021, Webinar. The digital healthcare ecosystem is evolving with rapid speed. Technologies such as AI, robotics, telemedicine, and precision medicine are a mix of challenges and opportunities...

Using AI for Early Detection and Treatme…

Artificial intelligence (AI) will fundamentally change medicine and healthcare: Diagnostic patient data, e.g. from ECG, EEG or X-ray images, can be analyzed with the help of machine learning, so that...

Waiting Times for Medical Admissions Red…

Clinicians at Bolton NHS Foundation Trust have dramatically reduced patient waiting times, decreased hospital length of stay and improved patient safety after developing an electronic acute medical list solution to manage patient referrals.  The configuration was initially set-up to track referrals and admissions...

AI Algorithm Solves Structural Biology C…

Determining the 3D shapes of biological molecules is one of the hardest problems in modern biology and medical discovery. Companies and research institutions often spend millions of dollars to determine...

Novel AI Blood Testing Technology can ID…

A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel Cancer Center was found to detect over 90% of lung cancers in samples from nearly...

Accenture HealthTech Innovation Challeng…

Accenture (NYSE: ACN) has named eight companies as finalists in the Accenture HealthTech Innovation Challenge, which brings together leading-edge startups with prominent health companies to tackle some of North America's...

Clinerion Patent for Technology Underpin…

The new Clinerion patent underpins any medical EHR database infrastructure that incorporates a hybrid model of cloud-and-local server node installations at individual hospitals, as well as any method for search...

Data MATRIX Introduces an AI-Operated Pa…

Data MATRIX, a sole Real-World Evidence solutions provider in Russia, has presented a predictive analytics tool for estimating patient survival based on Real-World Data. An important feature of the presented tool for...

Researchers Use AI to Predict which COVI…

Researchers at Case Western Reserve University have developed an online tool to help medical staff quickly determine which COVID-19 patients will need help breathing with a ventilator. The tool, developed through...

A Game Changer: Virtual Reality Reduces …

It isn’t a matter of one needle puncture. Many children coming through the doors of Children's Hospital Los Angeles are seen for chronic conditions and often require frequent visits. Painful...

Bittium Expands Its Minority Holdings in…

Bittium Biosignals Ltd, a subsidiary of Bittium Corporation, and British ECG service provider, Technomed Limited, have today signed an agreement under which Bittium will purchase a 25 percent stake in...

Scientists Develop AI to Predict the Suc…

A study in which machine-learning models were trained to assess over 1 million companies has shown that artificial intelligence (AI) can accurately determine whether a startup firm will fail or...